MX2007006837A - Difluoronucleosidos y proceso de preparacion de los mismos. - Google Patents

Difluoronucleosidos y proceso de preparacion de los mismos.

Info

Publication number
MX2007006837A
MX2007006837A MX2007006837A MX2007006837A MX2007006837A MX 2007006837 A MX2007006837 A MX 2007006837A MX 2007006837 A MX2007006837 A MX 2007006837A MX 2007006837 A MX2007006837 A MX 2007006837A MX 2007006837 A MX2007006837 A MX 2007006837A
Authority
MX
Mexico
Prior art keywords
protected
base
preparation
group
difluorofuranose
Prior art date
Application number
MX2007006837A
Other languages
English (en)
Spanish (es)
Inventor
Marco Villa
Anne-Ruth Born
Pierre Martin
Dirk Spielvogel
Original Assignee
Sicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sicor Inc filed Critical Sicor Inc
Publication of MX2007006837A publication Critical patent/MX2007006837A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048—Pyridine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2007006837A 2004-12-08 2005-12-08 Difluoronucleosidos y proceso de preparacion de los mismos. MX2007006837A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63437604P 2004-12-08 2004-12-08
PCT/US2005/044369 WO2006063105A1 (en) 2004-12-08 2005-12-08 Difluoronucleosides and process for preparation thereof

Publications (1)

Publication Number Publication Date
MX2007006837A true MX2007006837A (es) 2007-10-23

Family

ID=36147231

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007006837A MX2007006837A (es) 2004-12-08 2005-12-08 Difluoronucleosidos y proceso de preparacion de los mismos.

Country Status (10)

Country Link
US (1) US20060173174A1 (enExample)
EP (1) EP1819718A1 (enExample)
JP (1) JP2007522151A (enExample)
KR (1) KR20070073958A (enExample)
CN (1) CN101076535A (enExample)
CA (1) CA2586687A1 (enExample)
IL (1) IL183702A0 (enExample)
MX (1) MX2007006837A (enExample)
TW (1) TW200634022A (enExample)
WO (1) WO2006063105A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2778B1 (en) 2007-10-16 2014-03-15 ايساي انك Certain Compounds, Compositions and Methods
US8329666B2 (en) 2009-04-06 2012-12-11 Eisai Inc. Compositions and methods for treating cancer
ES2593088T3 (es) 2009-04-06 2016-12-05 Otsuka Pharmaceutical Co., Ltd. Derivados de (2'-Desoxi-Ribofuranosil)-1,3,4,7-Tetrahidro-(1,3)Diazepin-2-ona para Tratamiento de Cáncer
US8609631B2 (en) 2009-04-06 2013-12-17 Eisai Inc. Compositions and methods for treating cancer
CA2757745C (en) 2009-04-06 2018-02-13 Eisai Inc. Combination of cytidine-based antineoplastic drugs with cytidine deaminase inhibitor and use thereof in the treatment of cancer
CN104130301B (zh) * 2014-08-13 2016-06-01 伦俊杰 一种盐酸吉西他滨中间体的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH541566A (de) * 1969-04-11 1973-09-15 Schering Ag Verfahren zur Herstellung von Nucleosiden
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
DE3587500T2 (de) * 1984-12-04 1993-12-16 Lilly Co Eli Tumorbehandlung bei Säugetieren.
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US5371210A (en) * 1992-06-22 1994-12-06 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5594124A (en) * 1992-06-22 1997-01-14 Eli Lilly And Company Stereoselective glycosylation process for preparing 2'-Deoxy-2',2'-difluoropyrimidine nucleosides and 2'-deoxy-2'-fluoropyrimidine nucleosides and intermediates thereof
US5606048A (en) * 1992-06-22 1997-02-25 Eli Lilly And Company Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
IL106078A0 (en) * 1992-06-22 1993-10-20 Lilly Co Eli Stereoselective anion glycosylation process
US5401838A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US6828346B2 (en) * 1999-10-25 2004-12-07 Supergen, Inc. Methods for administration of paclitaxel
AU2003291726A1 (en) * 2002-11-04 2004-06-07 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
CN1228342C (zh) * 2003-04-08 2005-11-23 深圳市汉德森技术有限公司 以1，6－脱水－β－D－葡萄糖为原料制备2'－脱氧－2'，2'－二氟－β－核胞苷或其药用盐的方法

Also Published As

Publication number Publication date
TW200634022A (en) 2006-10-01
JP2007522151A (ja) 2007-08-09
CA2586687A1 (en) 2006-06-15
KR20070073958A (ko) 2007-07-10
WO2006063105A1 (en) 2006-06-15
IL183702A0 (en) 2007-09-20
EP1819718A1 (en) 2007-08-22
CN101076535A (zh) 2007-11-21
US20060173174A1 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
EP1604665A4 (en) C-KIT KINASE HEMMER
WO2006084017A3 (en) Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
IL144668A0 (en) The use of 4-h-1-benzopyran-4- one derivatives as inhibitors of smooth muscle cell proliferation
MY144322A (en) 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
TW200635930A (en) Bicyclic pyrrole derivatives
AU2003264060A8 (en) Phenacyl xanthine derivatives as dpp-iv inhibitor
TW200607806A (en) Pyrimidines as plk inhibitors
WO2006044958A8 (en) Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists
UA84275C2 (ru) 8-[3-аминопиперидин-1-ил]ксантины, способ их получения и их применение как лекарственных средств
WO2004046148A8 (de) Neue xanthinderivate, deren herstellung und deren verwendung als arzneimittel
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
MY136242A (en) Purine derivatives
IL163781A0 (en) Purine derivatives as kinase inhibitors
ATE393769T1 (de) Stickstoff substituierte hexahydro-pyrazino 1,2-a pyrimidin-4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
TW200740758A (en) Benzoquinazoline derivatives
TW200512210A (en) Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
WO2008087933A1 (ja) ＩκＢキナーゼβ阻害活性を有する新規インドール誘導体
TW200724540A (en) Heterocyclic antiviral compounds
TW200612958A (en) Substituted imidazole derivatives
IL182504A0 (en) Coating compositions, articles, and methods of coating articles
GB0308201D0 (en) Novel compounds
MX2009005071A (es) Compuestos de pirazol y triazol sustituidos como inhibidores de ksp.
WO2006000371A3 (en) Pyrimidine derivatives as 11beta-hsd1 inhibitors
GEP20094697B (en) Condensed purine derivatives as a1 adenosine receptor antagonists
AU4579500A (en) Small electronic articles for personal use